Sunshine Act. Each of the Company and Executive acknowledge that certain state or federal laws now or in the future may require Novavax to disclose information regarding compensation, funding, gifts, payments or other remuneration (“Remuneration”) provided to physicians and other members of the health care community. Novavax may report information about Remuneration provided under this Agreement as required by applicable law. Once reported, such information will be publicly accessible.
Sunshine Act. Each Party acknowledges that, under the provisions of Section 1128G of the Social Security Act, 42 U.S.C. § 1320a-7h and other similar provisions of Applicable Law, such Party may be required to disclose certain payments and other transfers of value provided to health care professionals and institutions, including payments, reimbursements, materials or equipment made or provided under or in connection with this Agreement or the development plans. Each Party will provide the other Party with all reasonable information in its Control related to the activities hereunder necessary for the other Party to comply with such Applicable Laws in the form reasonably requested by the requesting Party and at such times as the requesting Party may reasonably request to satisfy its obligations.
Sunshine Act. Each Party shall report any reportable payments or transfers of value that it makes in connection with this Agreement to covered recipients pursuant to §6002 of the Affordable Care Act of 2010, and other similar laws.
Sunshine Act. In compliance with specific Donor reporting requirements, OMeGA will report to Donor(s) such information Donor requires in order to achieve compliance under the Sunshine Act, all in connection with this grant.
Sunshine Act. Allergan and Exicure acknowledge that, under the provisions of Section 1128G of the Social Security Act, 42 U.S.C. § 1320a-7h and other similar provisions of applicable Law, Allergan and Exicure may be required to disclose certain payments and other transfers of value provided to health care professionals and institutions, including payments, reimbursements, Materials or equipment made or provided under or in connection with this Agreement or the Development Plans. Each of Exicure and Allergan will provide the other Party with all information necessary for the other Party to comply with such applicable Laws in the form reasonably requested by the requesting Party and at such times as the requesting Party may reasonably request to satisfy its obligations.
Sunshine Act. If Sales Agent makes reportable payments or transfers of value under the federal Physician Payments Sunshine Act (the “Sunshine Act”) to any physicians or qualified healthcare provider (i.e., MD, DO, OD, DC, DPM, DDS), advance practice nurses, physician assistants or teaching hospitals on behalf of Company, Sales Agent shall be responsible for collecting and submitting to Company any information that Company is required to report to the government (“Covered Information”). Sales Agent will be responsible for timely implementing processes and systems necessary to capture, store and report to Company all Covered Information. Sales Agent will be responsible for the accuracy and completeness of its Covered Information. Sales Agent will be responsible for any and all costs incurred by the Company as a result of inaccuracy or incompleteness, including, without limitations, fines and penalties levied by the federal government against Company. Sales Agent will retain complete records of all Covered Information for the period required under the Sunshine Act and will make such records available for periodic audit by Company.
Sunshine Act. Distributor shall be responsible for complying with all applicable obligations under the federal Physician Payments Sunshine Act (the "Sunshine Act") relating to any reportable payments or other transfers of value to "covered recipients" (as that term is defined in the Sunshine Act) and teaching hospitals made by Distributor. In addition, if Distributor makes reportable payments or transfers of value to covered recipients or teaching hospitals on behalf of Company that are reportable by Company, Distributor shall be responsible for collecting and reporting to Company any information that Company is required to report to any government or regulatory authority ("Covered Information"). Distributor is responsible for timely implementing business processes and systems necessary to capture, store and report to Company all Covered Information. Furthermore, Distributor will be responsible for the accuracy and completeness of its Covered Information and will be required to certify to such accuracy and completeness to Company with each submission. Distributor will retain complete records of all Covered Information for the period required under the Sunshine Act and will make such records reasonably available for audit by Company in accordance with the audit provisions of Section 11 of this Exhibit and/or Section 20 of the Agreement.
Sunshine Act. Illumina and Partner acknowledge that they both may be “Applicable Manufacturers” pursuant to the Physician Payment Sunshine Act and may have certain duties to track and report payments and transfers of value to “Covered Recipients”, as those terms are defined by the Centers for Medicare & Medicaid Services, or a successor entity thereto. To the extent either Party has reporting obligations under the Physician Payment Sunshine Act, upon the reasonable request of the reporting Party the other Party will provide such reporting Party with complete and accurate information about payments or transfers of value in relation to the activities under this Agreement that are reportable thereunder. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE KURA ONCOLOGY, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO KURA ONCOLOGY, INC. IF PUBLICLY DISCLOSED.
Sunshine Act. In compliance with reporting requirements, Administrator will report to Donor(s) such information Donor requires in order to achieve compliance under the Sunshine Act, all in connection with this grant.
Sunshine Act. Recipient acknowledges and agrees that the transfer of the Materials by AstraZeneca to the Recipient may be deemed as a transfer of value as defined in the U.S. Physician Payment Sunshine Act (42 USC §1320(e)(10)), and implementing regulations (42 CFR §§403.900 et seq.). Recipient further acknowledges and agrees that such transfer may be subject to transparency reporting requirements, including disclosure on AstraZeneca’s website.
